Loading clinical trials...
Loading clinical trials...
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Associated Inferior Vena Cava Tumor Thrombus (NEOPAX)
Conditions
Interventions
Axitinib
Pembrolizumab
Locations
3
United States
University of Colorado Cancer Center
Aurora, Colorado, United States
Hilands Ranch Hospital
Highlands Ranch, Colorado, United States
Lone Tree Medical Center
Lone Tree, Colorado, United States
Start Date
December 4, 2023
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2029
Last Updated
April 13, 2026
NCT07227402
NCT07540260
NCT00033137
NCT05969860
NCT04693377
NCT07117227
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions